Issue 57, 2022

Pre-targeting of polymeric nanomaterials to balance tumour accumulation and clearance

Abstract

Pre-targeting of bispecific antibodies is probed to enhance tumour retention while limiting clearance of administered multifunctional branched PEGylated nanomedicines. The temporal influence of pre-targeting on polymer interaction with tumour cells and tissue is explored using in vitro assays through to preclinical validation.

Graphical abstract: Pre-targeting of polymeric nanomaterials to balance tumour accumulation and clearance

Supplementary files

Article information

Article type
Communication
Submitted
30 апр. 2022
Accepted
09 јун. 2022
First published
21 јун. 2022

Chem. Commun., 2022,58, 7912-7915

Pre-targeting of polymeric nanomaterials to balance tumour accumulation and clearance

N. L. Fletcher, A. Prior, O. Choy, J. Humphries, P. Huda, S. Ghosh, Z. H. Houston, C. A. Bell and K. J. Thurecht, Chem. Commun., 2022, 58, 7912 DOI: 10.1039/D2CC02443H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements